Newcelx Ltd

Penny Stocks Biotech Stocks Healthcare Stocks

$3.73

+0.04 (+1.08%)

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +987.7% upside

Low Target $36.99

Average Target $40.57

High Target $64.99

Current Price $3.73

Current
$3.73

Target
$40.57

$36.99 $40.57 avg $64.99

Scenario Analysis

Bear Case

$36.99

891.7%

Low target

Base Case

$40.57

+987.7%

Avg target

Bull Case

$64.99

+1,642.4%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$30.80

-87.9% from high

52-Week Low

$1.83

+103.8% from low

Target vs 52W High

$40.57

+31.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.2%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.4%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.6%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-38.5%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-48.0%